ONCOSENX

oncosenx-logo

OncoSenX is a developer of transient gene therapies designed for solid tumors. The company's therapy delivers plasmid DNA with a novel lipid nanoparticle that selectively kills cancerous cells based on their transcriptional activity, providing cancer patients, doctors and medical care professionals with a less invasive and more precise intervention for this complex and devastating disease.

#SimilarOrganizations #People #Financial #Website #More

ONCOSENX

Social Links:

Industry:
Biotechnology Health Care

Founded:
2017-01-01

Address:
Seattle, Washington, United States

Country:
United States

Website Url:
http://www.oncosenx.com

Total Employee:
1+

Status:
Active

Total Funding:
11.7 M USD

Technology used in webpage:
Google Apps For Business Squarespace Hosted


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

geneos-therapeutics-logo

Geneos Therapeutics

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

obsidian-therapeutics-logo

Obsidian Therapeutics

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.


Current Advisors List

kristin-bedard_image

Kristin Bedard Scientific Advisory Board Member @ OncoSenX
Advisor
2019-02-01

Current Employees Featured

stephen-hilbert_image

Stephen Hilbert
Stephen Hilbert Chief Business Officer @ OncoSenX
Chief Business Officer
2017-11-01

eric-garcia_image

Eric Garcia
Eric Garcia Chief Operating Officer @ OncoSenX
Chief Operating Officer

john-lewis_image

John Lewis
John Lewis CSO @ OncoSenX
CSO

matthew-scholz_image

Matthew Scholz
Matthew Scholz CEO @ OncoSenX
CEO

Founder


john-lewis_image

John Lewis

matthew-scholz_image

Matthew Scholz

Investors List

althea-group-ventures_image

Althea Ventures

Althea Ventures investment in Seed Round - OncoSenX

canadian-institutes-of-health-research_image

Canadian Institutes of Health Research

Canadian Institutes of Health Research investment in Grant - OncoSenX

jim-mellon_image

Jim Mellon

Jim Mellon investment in Pre Seed Round - OncoSenX

sens-foundation_image

SENS Foundation

SENS Foundation investment in Pre Seed Round - OncoSenX

helios-capital-1131_image

Helios Capital

Helios Capital investment in Pre Seed Round - OncoSenX

kingsley-advani_image

Kingsley Advani

Kingsley Advani investment in Pre Seed Round - OncoSenX

kingsley-advani_image

Kingsley Advani

Kingsley Advani investment in Pre Seed Round - OncoSenX

benjamin-kong_image

Benjamin Kong

Benjamin Kong investment in Pre Seed Round - OncoSenX

avant-global_image

Avant Global

Avant Global investment in Seed Round - OncoSenX

Official Site Inspections

http://www.oncosenx.com Semrush global rank: 5.99 M Semrush visits lastest month: 1.37 K

  • Host name: 198.49.23.145
  • IP address: 198.49.23.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "OncoSenX" on Search Engine